Back
Aprea Therapeutics 10K Form
Sell
30
APRE
Aprea Therapeutics
Last Price:
2.60
Seasonality Move:
-39.53%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive APRE News And Ratings
See the #1 stock for the next 7 days that we like better than APRE
APRE Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-3.65M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.71 |
| Price / Book: | 0.55 |
Profitability
| EPS (TTM): | -3.03000 |
|---|---|
| Net Income (TTM): | $-12.93M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Aprea Therapeutics Earnings Forecast
Key Aprea Therapeutics Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 7 years have been positive in 3 years.
Aprea Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | APRE |
| CUSIP: | 03836J |
| Website: | aprea.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
APRE Technical Analysis vs Fundamental Analysis
Sell
30
Aprea Therapeutics (APRE)
is a Sell
Is Aprea Therapeutics a Buy or a Sell?
-
Aprea Therapeutics stock is rated a Sell
The current Aprea Therapeutics [APRE] share price is $2.60. The Score for APRE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.